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Aim: Dukes’ staging system is a simple system used widely in the staging of colorectal cancer. This study was
designed to analyze the applicability of the modified Dukes’ classification system in gastric cancer cases.
Methods: The prognostic factors affecting survival in 139 gastric cancer cases who had had at least 15 lymph
nodes removed were analyzed. Modified Dukes’ and TNM classifications were investigated to correlate
statistically significant prognostic factors. The investigated prognostic factors were age, tumor size,
histological type, differentiation, localization and number of the lymph nodes removed, and the ratio of
number of metastatic lymph nodes to the number of lymph nodes removed.
Results: Tumor size >10 cm, muscularis propria and serosa invasion, >6 invaded lymph nodes and metastatic
lymph node ratio >0.29 were statistically significant poor prognostic factors in multivariate analysis. The two
staging systems were in correlation with these poor prognostic factors. There was no statistical difference
between receiver operating characteristics curves of the two systems. When the survival curves were
examined, it was seen that Dukes’ staging had a more stepwise curve than the TNM system.
Conclusion: Dukes’ staging system is in correlation with prognostic factors in gastric cancer. It can be easily
recalled. Dukes’ A stage when applied to gastric cancer defines a good prognosis group. The reclassification of
T2N0 tumors as early gastric cancer is an area of speculation which needs to be investigated separately.
Key Words: Gastric cancer, Dukes’ classification, prognostic factors, staging systems

Modifiye Dukes S›n›flamas› Mide Kanseri Evrelemesinde Kullan›labilir mi?
Amaç: Dukes evreleme sistemi kolorektal kanser evrelemesinde yayg›n olarak kullan›lan basit bir evreleme
sistemidir. Bu çal›ﬂma modifiye Dukes s›n›flamas›n›n mide kanseri olgular›nda uygulanabilirli¤ini araﬂt›rmak
amac›yla düzenlenmiﬂtir.
Yöntemler: Cerrahi de en az 15 lenf nodülü ç›kar›lm›ﬂ 139 mide kanserli olgunun yaﬂam sürelerine etkili
faktörler analiz edildi. Modifiye Dukes ve TNM evrelerinin bu prognostic faktörlerle olan korelasyonu saptand›.
Araﬂt›r›lan faktörler yaﬂ, tümor büyüklü¤ü, histolojik tip, diferansiasyon, lokalizasyon, ç›kart›lan lenf nodülü
say›s›, metastatik lenf nodülü say›s› ve metastatik lenf nodülü say›s›n›n ç›kart›lan lenf nodülü say›s›na oran›d›r.
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Bulgular: Tümör çap›n›n 10 cm’den büyük olmas›, muskularis propria and seroza invazyonu, metastatik lenf
nodülü say›s›n›n 6’dan büyük olmas›, metastatik lenf nodülü oran›n›n 0.29’dan büyük olmas› çok yönlü analizde
istatistiksel anlaml› kötü prognostic faktörler olarak bulundu. Her iki evreleme sistemi de bu faktörlerle
korelasyon gösteriyordu. Receiver operating characteristics curves (ROC) analizinde her iki evreleme sistemi
aras›nda istatistiksel fark yoktu. Sa¤ kal›m e¤rileri incelendi¤inde Dukes evrelemesi TNM’ye gore daha
basamakl› bir e¤riye sahipti.
Sonuç: Dukes evreleme sistemi mide kanserindeki prognostic faktörlerle korelasyon göstermektedir. Kolayca
ak›lda tutulabilir. Dukes A stage evresi iyi prognoza sahip bir grubu tan›mlar. T2N0 hastalar›n erken mide
kanseri olarak tan›mlanmas› ayr›ca incelenmesi gereken bir konudur.
Anahtar Sözcükler: Mide kanseri, Dukes s›n›flamas›, prognostik faktörler, evreleme sistemleri

ozguch@uludag.edu.tr
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Introduction
A tumor case is staged in order to obtain information
about the patient’s prognosis and to compare it with
other case series. It is also useful in arranging the
treatment and evaluating success. Preferably, staging
systems should be simple, easily applicable and
understandable.
For gastric cancer the two major tumor-related
prognostic factors are depth of invasion and lymphatic
invasion. Two systems that are widely used in gastric
cancer staging are also based on these variables. One of
these systems is a Japanese staging system developed by
the Japanese Research Society for Gastric Cancer and the
other, which is more widely used in Western countries, is
the TNM staging system developed by the International
Union Against Cancer (IUCC). Aside from serving as a
means of staging, the Japanese system anatomically
separates the gastric lymphatic system into groups, and it
can be used as a guide for surgery. It is quite complicated
and requires expertise. The modified version of the TNM
classification, developed in 1997, takes into consideration
the depth of invasion and number of lymph nodes. It is
more practical and easily applicable than the Japanese
classification system and is more widely used in Western
societies. However, more than one patient group is found
in each stage, which can be confusing (1,2,3). In the
West, the decrease in gastric cancer incidence has led to
less frequent gastric cancer operations by surgeons (4).
This can be a factor limiting the application of the TNM
system in clinical practice.
The Dukes’ staging system is a simple system used
widely in the staging of colorectal cancer. Its applicability
in gastric cancer was studied by Adachi et al. (5), and was
shown to be a simple and easily applicable prognostic
system. In their study, the Dukes’ system used in
colorectal cancer was modified according to the number
of invaded lymph nodes. It was determined that this
system was in correlation with other prognostic factors
influential in gastric cancer (6). There are also studies
concerning its use in esophagus cancer (7). Gastric cancer
characteristics and survival results in Western societies
show significant differences from the results of Japanese
studies. Therefore, widespread applicability of such a
system requires studies done in various countries. This
study was designed to analyze the applicability of the
modified Dukes’ classification system, to compare it with
the TNM system and to investigate the correlation with
272
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prognostic factors in gastric cancer cases with more than
15 lymph nodes removed.

Patients and Methods
In this study, 441 cases that were operated for gastric
cancer between January 1992 and November 2002 in the
General Surgery Department, Uludag University Faculty
of Medicine, were retrospectively reviewed. Inclusion
criteria included cases with total or subtotal gastric
resection and more than 15 lymph nodes dissected. Cases
with distant or peritoneal metastases, gastrointestinal
stromal tumors, diagnosis of gastric lymphoma,
inadequate records, unknown survival period, and those
who died in hospital in 30 days were excluded from the
study. Type I and II tumors of esophagogastric junction
were excluded but Type III tumors were included. After
evaluation of these criteria, 142 cases with interventions
other than resections, 76 cases with insufficient lymph
node numbers, 17 cases with lymphoma and stromal
tumor diagnosis, 13 exitus cases and 54 cases with
inadequate records were excluded and totally 139 cases
were included in the study.
The postoperative survival times and the prognostic
factors affecting survival for the 139 cases included in the
study were analyzed. The correlation between the
statistically significant prognostic factors and the
modified Dukes’ system was investigated. The
investigated prognostic factors were age, tumor size,
histological type, Borman classification (according to
pathologic description), differentiation, localization and
number of the lymph nodes removed and the ratio of
number of metastatic lymph nodes to the number of the
removed lymph nodes (mln/rln). For Dukes’ classification,
the modified Dukes’classification as suggested by Adachi
et al., which involved invasion depth and number of
lymph nodes saved, was used (5,6). In this system, there
are three groups in accordance with the original system.
Dukes’ A cases were cases with invasion of mucosa,
submucosa and muscularis propria without lymphatic
invasion. Dukes’ B cases had subserosal or serosal
invasion without lymph node involvement. Dukes’ C cases
were divided into two subgroups according to the
number of invaded lymph nodes. Dukes’ Ca were cases
with any level of invasion of wall with 1-6 lymph nodes
involved. Dukes’ Cb cases had any level of invasion of wall
with at least 7 lymph nodes involved. In Figure 1,
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Figure 1. Modified Dukes’ staging and corresponding TNM distribution.

modified Dukes’ staging system and corresponding TNM
distribution for each group is demonstrated.
The Statistical Package for Social Sciences (SPSS)
version 10 (SPSS, Chicago, IL, USA) was used for all
calculations. Fisher’s exact and Mann-Whitney U tests
were used for statistical comparisons of contingency
tables and nonparametric values. Descriptive data were
expressed as mean ± standard deviations. Pearson’s
correlation analysis was performed to describe the linear
association between prognostic factors, Dukes’
classification and TNM classification. Cut-off points were
determined to class risk factors into two groups by the
use of receiver operating characteristics (ROC). An ROC
curve is simply a graph of sensitivity vs (1-specificity) for
different values (which also change the sensitivity and
specificity). The best value for balancing the sensitivity
and specificity of the variable is the one represented by
the point on the curve closest to the upper left-hand

corner accepted cut-off. Comparison of ROC curves of
Dukes’and TNM classification was performed. Survival
curves were constructed by the Kaplan-Meier method.
The significance of all investigated prognostic factors for
postoperative survival was examined by log-rank test. In
multivariate analysis of survival, Cox regression model
was used to compare all prognostic factors found to be
significant in univariate analysis in order to identify
independent predictors of survival. A p value <0.05 was
considered significant.

Results
Univariate analysis showed tumor size >10 cm, linitis
plastica and proximal location, invasion depth, lymph
node invasion, insufficient differentiation, and mln/rln
ratio >0.29 to be significantly correlated with poor
survival. The relationship between the investigated
prognostic factors and survival are shown in Table 1.
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Table 1. Results of univariate analysis (met: Metastatic. M: mucosa. sm: Submucosa. Mp: Muscularis propria. Ss: Subserosa, S: Serosa).

Risk Factor

Number of Patients

5-Year Survival (%)

Mean Survival (Month)

P Value

Invasion
M,sm(T1)
Mp(T2)
Ss,S(T3)
(T4)

8
17
103
11

100
61
22
11

65.1 ± 8.1
93 ± 14
57 ± 7.1
21 ± 9.8

0.0002

Nodal status
N0
N1(1-6)
N2(7-15)
N3>15

43
27
38
31

72
36
12
6

117 ± 10
69 ± 16
38 ± 7.2
13 ± 1.7

0.00..

Location
Distal
Midgastric
Proximal
Diffuse

56
51
25
7

34
61
0
0

67 ± 10
75 ± 9.6
32 ± 7.5
11 ± 3.3

0.016

Organ resection
Present
Absent

49
90

25
35

39.7 ± 5.6
41.4 ± 5.32

0.06

Size
<5 cm
5-10 cm
>10 cm

39
74
26

61
27
0

101 ± 12
59 ± 8.6
23 ± 6.2

0.00..

Borman classification
Type 1
Type 2
Type 3
Type 4

5
16
84
34

20
78
34
14

26 ± 5.3
123 ± 15
67 ± 8.5
37 ± 8.6

0.042

Differentiation
Good
Moderate
Poor

7
43
89

50
28
30

85 ± 32
71 ± 12
52 ± 6.2

0.045

No of met. lymp node
<4
≥4

63
76

73
9

115 ± 8.8
30 ± 4.6

0.00..

Ratio of met. node
≤0.29
>0.29

74
65

65
2

111 ± 8.6
19 ± 2.2

0.000

TOTAL

139

33

66.6 ± 6.47
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Prognostic factors significant in univariate analysis
were investigated in multivariate analysis. In multivariate
analysis, tumor size >10 cm (odds ratio: 4.69, p: 0.03),
muscularis propria (odds ratio: 4.7, p: 0.029) and serosa
invasion (odds ratio: 4.9, p: 0.026), number of invaded
lymph nodes >6 (odds ratio: 3.7, p: 0.045) and mln/rln
ratio >0.29 (odds ratio: 7.5, p: 0.006) were significant
independent prognostic factors (Table 2). It was
determined that the two staging systems were in
correlation with these poor prognostic factors in
correlation analysis.
Overall five-year survival rate was 33%; the mean
overall survival was 66.6 months. In Figure 2, survival
curve for all cases is shown. Sensitivity and specificity for
both staging systems were investigated by ROC analysis.
Cut-off points were determined as stage Ca for Dukes’
staging and IIIA for TNM staging. For these cut-off
points, sensitivity and specificity of Dukes’staging were
70% and 81.3% versus 71.6% and 79.3%, respectively,
for TNM staging. There was no statistical difference
between ROC curves of these two systems (p: 0.561).
The results of ROC analysis are presented in Table 3.

Table 2. Results of multivariate analysis (Rate: Ratio of number of
metastatic lymph nodes to number of the removed lymph
nodes).
Factor

Odds Ratio

P Value

T2 Invasion

4.7

0.029

T3 Invasion

4.9

0.026

Size >10 cm

4.69

0.03

Positive Node >6

3.7

0.045

Rate > 0.29

7.5

0.006
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Figure 2. Kaplan-Meier survival curve for all patients. The five-year
survival was 33% and mean survival time was 66.6 months.

Most of our cases were in advanced stages.
Distribution of cases according to stage is shown in Figure
3. Five-year survival rates were 100% in Dukes’ A stage,
84% in Dukes’ B stage (mean survival: 131 months),
30% in Dukes’ Ca stage (mean survival: 59 months), and
9% in Dukes’ Cb stage (mean survival: 30.8 months).
Excluding between Dukes’ stages A and B, there were
statistically significant differences in survival times
between stages (p: 0.25 = Dukes’ A vs B, p: 0.001 =
Dukes’ B vs Ca, p: 0.008 = Dukes’ Ca vs Cb). According
to TNM staging system, five-year survival in stage IA was
100% and in stage IB 87% (mean survival: 89 months),
in stage II 85% (mean survival: 132 months), in stage
IIIA 28% (mean survival: 58 months), in stage IIIB 12%
(mean survival: 40 months) and in stage IV 7% (mean
survival: 18 months). There were no statistically
significant differences between stages IA, IB and II;

Table 3. The results of ROC analysis (CI: Confidence interval. AUC: Area under curve). There was no statistically significant difference between
staging systems (p: 0.561).

Staging System

Criteria of
cut-off point

Sensitivity
(95% CI)

Specificity
(95% CI)

AUC
(95% CI)

Dukes staging

Ca

%70
(61.9–84.1)

81.3
(71.2–92.2)

0.844
(0.766–0.904)

TNM staging

IIIA

%71.60
(62.3–85.2)

79.3
(70.4–91.3)

0.865
(0.791–0.921)
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Figure 3. Distribution of cases according to stages for the two
classification systems.

statistically significant difference began after stage IIIA.
There was no statistically significant difference between
stage IIIB and IV (p: 0.32 = stage IA vs IB, p: 0.76 =
stage IB vs II, p: 0.001 = stage II vs IIIA, p: 0.002 = stage
IIIA vs. IIIB, p: 0.17 = stage IIIB vs. IV). Survival analysis
results according to both systems are shown in Figure 4.
In the subgroup investigation of our cases, number of
T1N0 cases was 8 and all were alive. There was only 1
T1N1 case. Only 1 of 13 cases in T2N0 was exitus (92%).
There was no statistically significant difference for
survival between the two groups (p: 0.68).
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Figure 4. Survival analysis for both classification systems. There were
statistically significant differences between Dukes’stages
excluding between stages A and B. For TNM classification,
there were no statistically significant differences between
stages IA, IB and II, but difference started with stage IIIA.
There was no significant difference between stage IIIB and
IV.

Discussion
There have been many studies in the literature that
investigated various prognostic factors affecting survival in
gastric cancer. Prognostic factors determined in our series
were in agreement with most of them (8,9,10). According
to results of the multivariate analysis, invasion depth,
tumor size, positivity of lymph nodes and mln/rln ratio
were found to be independent prognostic factors. Mln/rln
ratio has been frequently used as a prognostic indicator,
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especially in Western publications, and it is accepted to be
an objective measure of the quality of lymph dissection
(11,12,13). Although different ratios have been reported
in the literature, ROC analysis in our study determined the
highest sensitivity and specificity values at a level of 0.29.
According to our results, a lower mln/rln ratio indicates
better survival. In cases with lymph node involvement, it
will be appropriate to achieve at least a 0.29 ratio. Dukes’
staging system has been widely used for 60 years
especially in colorectal cancer staging. This system is a
simple and valuable staging system based on invasion
depth and whether or not there is lymph node
involvement. Adachi et al. was the first to apply it in gastric
cancer staging (5). In this study, the C stage of the original
Dukes’ staging system was modified by dividing it into two
stages according to number of metastatic lymph nodes as
Ca (1-6 nodes) and Cb (>6 nodes). In gastric cancer
staging, the modified Dukes’ system was considered to be
a simple and easily applicable staging system. One such
study conducted by the same authors in recent years
showed that this system was in correlation with prognostic
factors, tumor progression and patient survival (6). In our
study, all the prognostic factors obtained were in
correlation with both TNM and the modified Dukes’
staging system. The most significant characteristic of the
modified Dukes’ staging is that it emphasizes lymph node
involvement. For this staging system, the cut-off point was
found to be Ca in ROC analysis, and this point is the first
stage of lymph node involvement. When the survival
curves were examined, it was seen that Dukes’ staging had
a more stepwise curve than the TNM system.
Many studies have shown the efficiency of these widely
used staging systems in survival analysis. The TNM system
in particular has been widely accepted and is known to be
an appropriate system to estimate survival (14,15). Is
there a need for a new system in addition to these two in
which prognostic values have been shown? We believe the
answer is “yes” for two reasons. First, although the TNM
system is not as complicated as the Japanese system, it can
be difficult to recall in daily practice, especially in Western
countries, because of the decreasing incidence in gastric
cancer and the fall in operation numbers per surgeon per
year (16,17). In the TNM system, one stage can include
different types of tumors such as T1N2M0 and T2N1M0.
Patients with these types of gastric cancer are accepted as
stage II. The second reason is related to the early diagnosis
of gastric cancer. The incidence of early gastric cancer is
35-60% in a Japanese series and 20-25% in Western

October 2006

countries, whereas this ratio is below 5% in developing
countries (4). In our study, the incidence of early gatric
cancer was 17/441 (3.8%) for all patients and 9/139
(6.4%) for patients included in the study. This indicates a
major health problem in our country. In early gastric
cancer cases, nodal invasion is the most important factor
affecting prognosis (18,19). In many studies, although
there is a significant survival difference between T1N0 and
T1N1 cases, survival is fairly good in T2N0 cases. Similar
findings were obtained in the study made by Kikuchi et al.
(20), in which 848 early gastric cancer cases were
investigated. Ten-year survival rate related to cancer was
87.2% for node-positive cases and 99.2% for -negative
cases. In multivariate analysis, lymph node positivity has a
6.9-fold negative effect on survival. The difference
between node-negative and -positive early gastric cancer
prognosis increases especially in 10-year survivals. In the
study in which Nogueira et al. (21) presented their 10-year
experience in early gastric cancer, while it was found that
presence of lymph node invasion is the most important
factor affecting survival, invasion depth was not
determined to relate with survival period. Adachi et al.
(22) divided 217 patients into three groups as T1N0,
T2N0 and T1N1 and determined 10-year survival rates in
their study as 94.7%, 96.9% and 85.1%, respectively. In
the T1N1 group, survival is statistically significantly less.
Cases in Dukes’ A may be defined as early gastric cancer
(22,23,24,25). Our results also support these findings. In
series in which the number of T1 cases is few, like ours,
including T2N0 cases in this group will increase the
number of patients in this series. This finding, especially in
countries like Turkey where early gastric cancer cases are
extremely low, calls to mind the need for a new definition
for early gastric cancer.
There may be two points of criticism of the analysis of
the series presented. First, 139 cases were included in the
study from among 441 cases operated. Second, it was
started not five but two years retrospectively. Though
including 139 cases from 441 in our study can be seen as
limiting the value of our results, the rate of cases excluded
from the study because of lack of survival follow-up and
inadequate records was only 12% (54/441). The main
problem is the excessive number of cases with palliative
surgical procedures and number of lymph nodes removed
of <15, which were removed when resection was done.
This situation can be seen as the case characteristic of our
country and an indication of inadequate lymph gland
dissection in our clinic. As our cases were mostly at
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advanced stage, follow-up started two years later, which is
a sufficient period for evaluating survival in these cases.
In conclusion, Dukes’ staging system is in correlation
with prognostic factors and can be easily recalled. This
study, which is the first series outside Japan with respect

Turk J Med Sci

to the applicability of the system, is in agreement with
other studies. Application of Dukes’ A stage in defining
early gastric cancer is one of the other important results
of our study and literature data. However, our case
number is insufficient to make a definite interpretation.
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